Press Releases

Securing the Integrity of Microneedle Structure Design and Optimization: CD Formulation's Performance Testing Approach

Alfa Chemistry Announces the Launch of Innovative IVD Products for Laboratory Use

Creative BioMart Provides a Wide Range of Biomarker Proteins for Research Use

Creative Biolabs Unveils ADC Services, Igniting Excitement in the Biotech Industry

Creative Biolabs, a prominent provider of groundbreaking biotechnology solutions, proudly announced the expansion of its antibody-drug conjugate (ADC) business with the introduction of novel services.

Creative Enzymes Unveils Advanced Substrate, Inhibitor, and Ligand Screening Services

Creative Enzymes Unveils the Creative SuperCut Series: Redefining Precision in Molecular Biology

Empowering Research Excellence: Alfa Chemistry's THEIC, D-Pantethine, and Methoxytriethyleneoxypropyltrimethoxysilane at the Forefront

PathAI Diagnostics Unveils World’s First AI-Assisted Laboratory Developed Test for MASLD and MASH

PathAI Diagnostics' test allows for the histologic scoring and staging of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH). It will be announced at the American College of Gastroenterology 2023 Meeting October 20-25 in Vancouver, Canada.

Censinet and First Health Advisory Partner to Deliver Comprehensive Cyber Risk Assurance to Health Sector

Partnership Enables Healthcare Organizations to Leverage Unique Risk Advisory Services and Purpose-Built Workflow Automation to Maximize Cyber Risk Reduction

CD Formulation's Scientists Share A Holistic Approach on How to Prepare Drug Microcapsules

BOC Sciences at TIDES Europe 2023: Key Chemicals and XDC Platform to Be Exhibited

BOC Sciences will attend "TIDES Europe: Oligonucleotide & Peptide Therapeutics", delivered as a hybrid event from 30 Oct - 1 Nov 2023, in Amsterdam, NL. Its high-yield nucleosides & nucleotides, as well as a newly launched XDC platform, will be exhibited in front of the industry.

Biotium Introduces New Highly-Selective Stains For Both Gram-Positive and Gram-Negative Bacteria

Biotium has announced the launch of its breakthrough BactoView™ Dead Stains and BactoView™ Viability Kits.

CD Genomics Introduces Cutting-Edge Degradome Sequencing Service Redefining Transcriptomics Research

CD Genomics Revolutionizes TCR-Seq Elevating Immune Repertoire Profiling to New Heights

CD Genomics Unveils Cutting-Edge CRISPR Screen Sequencing Technology

JPA HEALTH EXPANDS LIFE SCIENCES DIVISION WITH ACQUISITION OF TRUE NORTH SOLUTIONS, INC.

Addition brings together synchronized experts to offer comprehensive predictive analytics, data visualization and AI-driven end-to-end solutions for life sciences, government and non-profit organizations

Expanding Research Horizons: CD Formulation Unveils its Redesigned Collection of Pharmaceutical Excipients

Innovative Synthetic Fibers Released by Alfa Chemistry: Discover Carbon, Ceramic, Glass, and Polymer Options

First Health Advisory Announces Rick LeMay as Executive Vice President of Enterprise Security & Technology

First Health Advisory recently welcomed Rick LeMay as its Executive Vice President of Enterprise Security & Technology to help advance the company's mission of providing digital health risk assurance to healthcare organizations.

Huateng Pharma Launches Gastrointestinal API Intermediates: Fexuprazan and Vonoprazan Intermediates

Huateng Pharma, a leading pharmaceutical ingredient manufacturer, has introduced a new product line, Gastrointestinal API Intermediates, featuring Fexuprazan and Vonoprazan Intermediates. These intermediates are designed to meet the increasing demand for high-quality solutions in gastrointestinal therapy. The products are available in both GMP and Non-GMP grades, boasting exceptional purity to facilitate the production of top-tier pharmaceuticals.